Familial follicular cell-derived thyroid carcinoma

Frontiers in Endocrinology

Volumn 3, Issue MAY, 2012, Pages

  Son, Eun Ju ^a   Nosé, Vânia ^b  

^a Yonsei University College of Medicine   (South Korea)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Carney complex; Cowden syndrome; Familial adenomatous polyposis; Familial papillary thyroid carcinoma; Familial thyroid carcinoma; Pendred syndrome,Werner syndrome

Indexed keywords

EID: 84874499674     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2012.00061     Document Type: Review

References (42)

1. Alsanea, O., and Clark, O. H. (2001). Familial thyroid cancer. Curr. Opin. Oncol. 13, 44-51.
2. Alsanea, O., Wada, N., Ain, K., Wong, M., Taylor, K., Ituarte, P. H., Treseler, P. A., Weier, H. U., Freimer, N., Siper-stein, A. E., Duh, Q. Y., Takami, H., and Clark, O. H. (2000). Is familial nonmedullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series. Surgery 128, 1043-1050; discussion 1050-1051.
3. American Cancer Society. (2007). Cancer Facts and Figures 2007. Atlanta, GA: American Cancer Society.
4. Bakhsh, A., Kirov, G., Gregory, J. W., Williams, E. D., and Ludgate, M. (2006). A new form of familial multi-nodular goitre with progression to differentiated thyroid cancer. Endocr. Relat. Cancer 13, 475-483.
5. Barletta, J. A., Bellizzi, A. M., and Hor-nick, J. L. (2011). Immunohisto-chemical staining of thyroidectomy specimens for PTEN can aid in the identification of patients with Cow-den syndrome. Am. J. Surg. Pathol. 35, 1505-1511.
6. Bevan, S., Pal, T., Greenberg, C. R., Green, H., Wixey, J., Bignell, G., Narod, S. A., Foulkes, W. D., Strat-ton, M. R., and Houlston, R. S. (2001). A comprehensive analysis of MNG1, TCO1, fPTC, PTEN, TSHR, and TRKA in familial nonmedullary thyroid cancer: confirmation of linkage to TCO1. J. Clin. Endocrinol. Metab. 86, 3701-3704.
7. Cameselle-Teijeiro, J., and Chan, J. K. (1999). Cribriform-morular variant of papillary carcinoma: a distinctive variant representing thesporadic counterpart of familial ade-nomatous polyposis-associated thyroid carcinoma? Mod. Pathol. 12, 400-411.
8. Carney, J. A., Gordon, H., Carpenter, P. C., Shenoy, B. V., and Go, V. L. (1985). The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore) 64, 270-283.
9. Cetta, F., Montalto, G., Gori, M., Curia, M., Cama,A., and Olschwang, S. (2000). Germline mutations of the APC gene in patients with FAP associated thyroid carcinoma. Results from a European cooperative study. J. Clin. Endocrinol. Metab. 85, 286-292.
10. Charkes, N. D. (2006). On the prevalence of familial nonmedullary thyroid cancer in multiple affected kindreds. Thyroid 16, 181-186.
11. Dotto, J., and Nosé, V. (2008). Familial thyroid carcinoma a diagnostic algorithm. Adv. Anat. Pathol. 15, 332-349.
12. Harach, H. R., Williams, G. T., and Williams, E. D. (1994). Familial ade-nomatous polyposis associated thyroid carcinoma: a distinct type of fol-licular cell neoplasm. Histopathology 25, 549-561.
13. Harach, R. (2001). Familial non-medullary thyroid neoplasia. Endocr. Pathol. 12, 97-112.
14. Hemminki, K., Eng, C., and Chen, B. (2005). Familial risks for non-medullary thyroid cancer. J. Clin. Endocrinol. Metab. 90, 5747-5753.
15. Herraiz, M., Barbesino, G., Faquin, W., Chan-Smutko, G., Patel, D., Shannon, K., Daniels, G., and Chung, D. (2007). Prevalence of thyroid cancer familial adenomatous polyposissyndrome and the role of screening ultrasound examinations. Clin. Gastroenterol. Hepatol. 5, 367-373.
16. Horner, M. J., Ries, L., Krapcho, M., Neyman, N., Aminou, R., Howlader, N., Altekruse, S., Feuer, E., Huang, L., Mariotto, A., Miller, B., Lewis, D., Eisner, M., Stinchcomb, D., and Edwards, B. (eds). (2009). SEER Cancer Statistics Review, 1975-2006.
17. Bethesda, MD: National Cancer Institute. Ishikawa, Y., Sugano, H., Matsumoto, T., Furuichi, Y., Miller, R., and Goto, M. (1999). Unusual features of thyroid carcinomas in Japanese patients with Werner syndrome and possible genotype-phenotype relations to cell type and race. Cancer Sci. 85, 1345-1352.
18. Lesueur, F., Stark, M., Tocco, T., Ayadi, H., Delisle, M. J., Goldgar, D. E., Schlumberger, M., Romeo, G., and Canzian, F. (1999). Genetic heterogeneity in familial nonmedullary thyroid carcinoma:exclusion of linkage to RET, MNG1, and TCO in 56 families. NMTC Consortium. J. Clin. Endocrinol. Metab. 84, 2157-2162.
19. Luk, G. (1995). Diagnosis and therapy of hereditary polyposis syndromes. Gastroenterologist 3, 153-167.
20. Malchoff, C. D., Sarfarazi, M., Tendler, B., Forouhar, F., Whalen, G., Joshi, V., Arnold, A., and Malchoff, D. M. (2000). Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome. J. Clin. Endocrinol. Metab. 85, 1758-1764.
21. Malchoff, C. D., Sarfarazi, M., Tendler, B., Forouhar, F., Whalen, G., and Malchoff, D. M. (1999). Familialpapillary thyroid carcinomais genetically distinct from familial adeno-matous polyposis coli. Thyroid 9, 247-252.
22. Matyakhina, L., Pack, S., Kirschner, L., Pak, E., Mannan, P., Jaikumar, J., Tay-mans, S., Sandrini, F., Carney, J., and Stratakis, C. (2003). Chromosome 2 (2p16) abnormalities in Carney complex tumours. J. Med. Genet. 40, 268-277.
23. Mazeh, H., Benavidez, J., Poehls, J. L., Youngwirth, L.,Chen, H.,and Sippel, R. S. (2012). In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease. Thyroid. 22, 3-8.
24. McKay, J. D., Lesueur, F., Jonard, L., Pastore, A., Williamson, J., Hoffman, L., Burgess, J., Duffield, A., Papotti, M., Stark, M., Sobol, H., Maes, B., Murat, A., Kääriäinen, H., Bertholon-Grégoire, M., Zini, M., Rossing, M. A., Toubert, M. E., Boni-chon, F., Cavarec, M., Bernard, A. M., Boneu, A., Leprat, F., Haas, O., Lasset, C., Schlumberger, M., Canzian, F., Goldgar, D. E., and Romeo, G. (2001). Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am. J. Hum. Genet. 69, 440-446.
25. McKay, J. D., Williamson, J., Lesueur, F., Stark, M., Duffield, A., Canz-ian, F., Romeo, G., and Hoffman, L. (1999). At least three genes account for familial papillary thyroid carcinoma: TCO and MNG1 excluded as susceptibility loci from a large Tas-manian family. Eur. J. Endocrinol. 141, 122-125.
26. Muftuoglu, M., Oshima, J., von Kobbe, C., Cheng,W., Leistritz, D., and Bohr, V. (2008). The clinical characteristics of Werner syndrome: molecular and biochemical diagnosis. Hum. Genet. 124, 369-377.
27. Musholt, T. J., Musholt, P. B., Petrich, T., Oetting, G., Knapp, W. H., and Klempnauer, J. (2000). Familial papillary thyroid carcinoma: genetics, criteria for diagnosis, clinical features, and surgical treatment. Wo r l d J. Surg. 24, 1409-1417.
28. Nehlin, J., Skovgaard, G., and Bohr, V. (2000). The Werner syndrome. A model for the study of human aging. Ann. N. Y. Acad. Sci. 908, 167-179.
29. Nosé, V. (2008). Familial non-medullary thyroid carcinoma: an update. Endocr. Pathol. 19, 226-240.
30. Nosé, V. (2010). Familial follicular cell tumors: classification and morphological characteristics. Endocr. Pathol. 21, 219-226.
31. Nosé,V. (2011). Familial thyroid cancer: a review. Mod. Pathol. 24(Suppl. 2), S19-S33.
32. Pan, L., Peng, L., Jean-Gilles, J., Zhang, X., Wieczorek, R., Jain, S., Levine, V., Osman, I., Prieto, V. G., and Lee, P. (2010). Novel PRKAR1A gene mutations in Carney complex. Int. J. Clin. Exp. Pathol. 3, 545-548.
33. Parisi, M. A., Dinulos, M. B., Lep-pig, K. A., Sybert, V. P., Eng, C., and Hudgins, L. (2001). The spectrum and evolution of phenotypic findings in PTEN mutation positive cases of Bannayan-Riley-Ruvalcaba syndrome. J. Med. Genet. 38, 52-58.
34. Soravia, C., Sugg, S., Berk, T., Mitri, A., Cheng, H., Gallinger, S., Cohen, Z., Asa, S.,and Bapat, B. (1999). Familial adenomatous polyposis-associated thyroid cancer: a clinical, pathological, and molecular genetics study. Am. J. Pathol. 154, 127-135.
35. Spigelman, A., Williams, C., Talbot, I., Domizio, P., and Phillips, R. (1989). Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 2, 783-785.
36. Stratakis, C. A., Courcoutsakis, N. A., Abati, A., Filie, A., Doppman, J. L., Carney, J. A., and Shawker, T. (1997). Thyroid gland abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and schwan-nomas (Carney complex). J. Clin. Endocrinol. Metab. [82,] 2037-2043.
37. Stratakis, C. A.,Kirschner,L. S.,and Carney, J. A. (1998). Carney complex: diagnosis and management of the complex of spotty skin pigmenta-tion,myxomas,endocrine overactiv-ity, and schwannomas. Am. J. Med. Genet. 80, 183-185.
38. Sturgeon, C., and Clark, O. H. (2005). Familial nonmedullary thyroid cancer. Thyroid 15, 588-593.
39. Vriens, M., Suh, I., Moses, W., and Kebebew, E. (2009). Clinical features and genetic predisposition to hereditary nonmedullary thyroid cancer. Thyroid 19, 1343-1349.
40. Xing, M. (2005). The T1799A BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancer. Clin. Endocrinol. (Oxf.) 63, 263-266.
41. Zambrano, E., Holm, I., Glickman, J., Huang, S., Perez-Atayde, A., Kozakewich, H. P., Shamberger, R. C., and Nosé, V. (2004). Abnormal distribution and hyperplasia of thyroid C-cells in PTEN-associated diseases. Endocr. Pathol. 15, 55-64.
42. Zhu, C., Zheng, T., Kilfoy, B. A., Han, X., Ma, S., Ba, Y., Bai, Y., Wang, R., Zhu, Y., and Zhang, Y. (2009). Airth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973-2004. Thyroid 19, 1061-1066.